Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-30

FDA Approved: ATOVAQUONE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved the original ANDA for atovaquone by Bionpharma Inc., authorizing a generic version of the medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atovaquone (Atovaquone)

Snippet

ORIG AP for ATOVAQUONE (ATOVAQUONE)